Chronic Disease News and Research

RSS

Promising new therapy for ulcerative colitis

For people with the chronic disease ulcerative colitis, life can be limited to few social functions and trips away from home.

6 Jan 2006

Lupus patients safe to go back on the pill

Two new studies confirm that women who suffer from lupus, a chronic disease that can lead to inflamed kidneys, can safely take oral contraceptives without fear that the pill will worsen their condition.

19 Dec 2005

High cholesterol may lead to high blood pressure in men

Men with high total cholesterol are much more likely to develop high blood pressure than men with low total cholesterol, according to a study in Hypertension: Journal of the American Heart Association.

15 Dec 2005

Perimenopause critical for preventing heart disease and osteoporosis

Research in monkeys suggests that the perimenopause - the five to 10 years before a woman's menopause - is a critical time for preventing heart disease and osteoporosis.

13 Dec 2005

Taking HRT before the menopause may prevent heart disease

According to American researcher Jay Kaplan, taking the "Pill" before the menopause or starting hormone replacement therapy before menopausal symptoms begin could actually help prevent heart disease in women.

6 Dec 2005

Health reform needs to be championed by health leaders

Health reform needs to be championed by health leaders, responsive to community needs and securely funded, to be sustained and benefit the health of Australians according to a new research published in the Medical Journal of Australia.

28 Nov 2005

Allergists help manage asthma better

Compared to patients receiving care from primary care physicians, asthma patients who are under the care of an allergist report fewer asthma control problems and less sever asthma symptoms, according to new research in the December 2005 Journal of Allergy & Clinical Immunology (JACI).

20 Nov 2005

Largest hepatitis-C U.S. study defines optimal therapy

Final results of the WIN-R trial,[1] the largest hepatitis C study conducted in U.S. patients, showed that weight-based REBETOL (ribavirin, USP) in combination therapy with PEG-INTRON (peginterferon alfa-2b) achieved significantly higher rates of sustained virologic response (SVR)[2] and lower rates of relapse compared to the combination therapy using a flat dose of ribavirin.

14 Nov 2005

New understanding of the disease process involved in atherosclerosis

The progression of the artery-clogging disease atherosclerosis is linked to the inability of specialized bone marrow cells to continuously repair damage to the arterial lining, Duke University Medical Center researchers have demonstrated.

13 Nov 2005

Chlamydia pneumoniae may cause vision problems

Researchers at the Massachusetts Eye and Ear Infirmary (MEEI) have found that Chlamydia pneumoniae, a bacterium linked to heart disease and capable of causing chronic inflammation, was present in the diseased eye tissue of five out of nine people with neovascular, or "wet," age-related macular degeneration (AMD).

7 Nov 2005

Diet high in soy does not increase the risk of uterine cancer in postmenopausal women

Cline said there has been much debate about whether high levels of dietary soy are safe for postmenopausal women. Soy products are sometimes sold as a natural alternative to traditional estrogen therapy, which does increase the risk of endometrial cancer.

3 Nov 2005

Growth patterns before birth, after birth and into childhood reveal a risk of coronary heart disease later in life

The risk of developing coronary heart disease as an adult is more strongly related to childhood growth patterns than body weight at any particular point in development, according to a new study published in the Oct. 27 New England Journal of Medicine. Coronary heart disease is the leading cause of death in the United States.

27 Oct 2005

Hope for better return for health spending in Australia

Health leaders have called for action in reforming primary health care to tackle the 'juggernaut' of chronic disease issues about to hit the health system at a meeting in Melbourne.

25 Oct 2005

Interactive health websites can help people live with their chronic illness

Contrary to the UCL group's original findings, the review - published by the Cochrane Library and revised after being found to contain errors - shows that people who use interactive health programs and websites generally have a better health outcome than non-users.

18 Oct 2005

Computer-assisted instruction offers the potential to overcome knowledge barriers and improve screening rates

Even patients with minimal education and no computer skills can be successfully educated about health topics using computers, according to new research at Wake Forest University Baptist Medical Center.

16 Oct 2005

Preventing Chronic Diseases: A Vital Investment

The European Society of Cardiology (ESC) is calling for concerted action following the recent release of an important report of the World Heart Organisation (WHO).

9 Oct 2005

To improve the diets of British children we need to look beyond school dinners

The health of pupils eating school dinners is no worse - and in some respects may be better - than that of pupils eating meals provided from home, concludes a study published online by the British Medical Journal today.

5 Oct 2005

Community-level intervention program successfully delayed sexual debut and increased the use of condoms

A community-level intervention program aimed at young adolescents delays early intercourse, increases condom use and reduces the type of risky sexual behavior that can result in sexually transmitted diseases and HIV/AIDS, a Yale researcher reports in AIDS.

4 Oct 2005

Lack of oxygen in body tissues creates a defect of red blood cells that further exacerbates the condition by constricting blood vessels in the lung

What's more, the team demonstrated through studies in people and animals that inhalation of a 'souped up' form of nitric oxide, which targets red blood cells, reverses the blood abnormality to restore normal lung pressure.

3 Oct 2005

Concerta, a once-daily form of the drug methylphenidate, successfully controlled ADHD symptoms

A new study has found that an all-day, extended-release stimulant for treating attention-deficit hyperactivity disorder (ADHD) remains effective for up to two years without significant side effects.

3 Oct 2005